Cargando…
Transplacental transfer of SARS-CoV-2 antibodies in recovered and BNT162b2-vaccinated patients
Autores principales: | Treger, Sharon, Shiloh, Sivan R., Ben-Valid, Tal, Ganor Paz, Yael, Sharvit, Merav, Bryk, Gabriel, Brosh-Nissimov, Tal, Barzilay, Eran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634700/ https://www.ncbi.nlm.nih.gov/pubmed/34863698 http://dx.doi.org/10.1016/j.ajog.2021.11.1365 |
Ejemplares similares
-
Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19
por: Brosh-Nissimov, Tal, et al.
Publicado: (2021) -
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study
por: Yechezkel, Matan, et al.
Publicado: (2023) -
Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents
por: Prunas, Ottavia, et al.
Publicado: (2022) -
Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose
por: Mofaz, Merav, et al.
Publicado: (2022) -
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
por: Brosh-Nissimov, Tal, et al.
Publicado: (2021)